Abstract:Metersky et al 1 present compelling evidence that adverse events (AEs), including medication errors and hospital-acquired infections (HAIs), increased among patients both with and without COVID-19 during weeks in which hospitals experienced greater COVID-19 admission burdens during the COVID-19 pandemic. The risk of AEs increased 9% with each 10% increase in COVID-19 burden, defined as the daily mean number of COVID-19 inpatients per 100 hospital beds. The investigation by Metersky et al 1 improved on the methods of existing work through its use of hospital-specific COVID-19 admissions data (rather than regional or aggregate hospital data) from the US Department of Health and Human Services (HHS) and its reliance on systematically adjudicated AEs from the Agency for Healthcare Research and Quality. The authors concluded with the recommendation to build more resilient systems of care to maintain patient safety during times of surge capacity. Indeed, these conclusions are well supported by the authors' approach and analysis, and this represents a public health call to action in the US to avoid excess morbidity and mortality in the future. However, still absent from the peer-reviewed literature is a discussion of the importance of hospital quality performance reporting and benchmarking in times of crisis as a mechanism to ensure safety. Hospitals in the US were effectively relieved of their obligations to provide high-quality pandemic-era care when pay-for-performance programs, 2 rankings, 3 and ratings 4 excluded months of pandemic-era data from their methods. Though ostensibly made with benign intent, these decisions to exclude pandemic-era quality-reporting data were not patient centered and may not have been methodologically necessary. 5 ,6 The findings of Metersky et al 1 demonstrate that quality and safety data are needed more than ever during times of crisis. This would allow patients and payers to understand which hospitals have resilient systems in order to make informed decisions about where they choose to receive and fund health care. For example, while Metersky et al 1 found only small differences in fall rates for patients without COVID-19 across hospitals with varying COVID-19 burden, a dose-response association was observed between increasing COVID-19 burdens and HAIs. We may therefore infer differences in systems and processes for fall prevention that allowed for greater resilience than systems and processes for prevention of HAIs. Logically, we could then consider whether exclusion of pandemic-era falls data from hospital-quality reporting was necessary. Exploring these nuances will be critical to identify where resilience in safety is lacking and to build resilience for the future. This may require the creation of pandemic-specific resilience action plans and self-reporting requirements by accrediting bodies, analogous to recent Joint Commission requirements for the reduction of health care disparities. Individual hospitals almost certainly varied in the specific domains of quality that were most and least resilient during the pandemic. Each hospital's least resilient system may represent low-hanging fruit or a starting point for building resilience. To date, however, finding these opportunities to build resilience has been a difficult task, in part due to the exclusion of pandemic-era benchmarking data. Ask chief quality officers to select any 3 among the hundreds of publicly reported quality measures (30-day readmissions, 30-day mortality, falls, HAIs, pressure ulcers, and so on) at which they believe their institution performed the worst during the pandemic, and you will likely get dozens of different answers. For many, the most truthful answer may be "I do not know," which hinders the ability to prioritize improvement. For example, if you knew that the 30-day hospital-wide readmissions rate had dropped from the 90th percentile of national performance to the 20th percentile of performance during the pandemic, there would be an important opportunity to consider which aspects of resilience specific to readmissions at your institution required improvement. With hospital-specific COVID-19 admissions data from HHS coupled with patient-level Medicare or other electronic health record or claims data, it is still possible to recreate the unreported pandemic-era quality outcomes benchmarks to identify resilient hospitals, systems, and processes during surge capacity. In fact, the Centers for Medicare & Medicaid Services' FY 2025 Inpatient Prospective Payment System Proposed Rule will extend the COVID-19 admissions data to include data for all respiratory illnesses. This will allow for the inclusion of future pandemic-era data in quality reporting using risk adjustment for hospitals' respiratory illness admission burdens rather than excluding months or years -Abstract Truncated-

Comparison of the Impact of COVID-19 on Veterans Affairs and Non-federal Hospitals: a Survey of Infection Prevention Specialists

The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce

Impact of the coronavirus disease-2019 pandemic on Veterans Health Administration Sleep Services

Comparing Catheter-Associated Urinary Tract Infection Prevention Programs Between Veterans Affairs Nursing Homes and Non-Veterans Affairs Nursing Homes

Association of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic

Veterans Affairs Training Experiences During the COVID-19 Pandemic-Trainee Satisfaction and Interest in Future Veterans Affairs Employment: A National Survey

Experiences of oncology researchers in the Veterans Health Administration during the COVID-19 pandemic

Lessons in Quality and Safety From Hospitals' COVID-19 Burdens

Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007-22)

What US hospitals are doing to prevent common device-associated infections during the coronavirus disease 2019 (COVID-19) pandemic: Results from a national survey in the United States

The impact of the COVID-19 pandemic on hospital-acquired infections at a comprehensive cancer center

The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network

Health Care-Associated Infections Among Hospitalized Patients With COVID-19, March 2020-March 2022

Hospital COVID-19 preparedness: Are (were) we ready?

Inpatient Care Experiences Differ for VA and Non-VA Hospitals, With Different Patterns by Health, Race, and Ethnicity

Effect of serious infectious threat response initiative (SITRI) during the coronavirus disease 2019 (COVID-19) pandemic at the Veterans Affairs North Texas Health Care System

Association Between Hospital Type and Resilience During COVID-19 Caseload Stress : A Retrospective Cohort Study

Risk of Potentially Preventable Hospitalizations After SARS-CoV-2 Infection

Leveraging the Million Veteran Program Infrastructure and Data for a Rapid Research Response to COVID-19

Changes in Outpatient Health Care Use After COVID-19 Infection Among Veterans

Virtual care expansion in the Veterans Health Administration during the COVID-19 pandemic: clinical services and patient characteristics associated with utilization